53-84-9 Tirzepatide Retatrutide Peptide Vials with NAD+ (Buffered)
TDS 126 Inquiries
53-84-9
Pharmaceutical Grade
99%
hongkong
TRANMOO
500mg*10vials
2027-02-28
Retatrutide
-
Product Details
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceNAD+ is a coenzyme composed of ribosylnicotinamide 5'-diphosphate coupled to adenosine 5'-phosphate by pyrophosphate linkage.
Solid
NAD zwitterion is a NAD. It has a role as a geroprotector. It derives from a deamido-NAD zwitterion. It is a conjugate base of a NAD(+).|A coenzyme composed of ribosylnicotinamide 5'-diphosphate coupled to adenosine 5'-phosphate by pyrophosphate linkage. It is found widely in nature and is involved in numerous enzymatic reactions in which it serves as an electron carrier by being alternately oxidized (NAD+) and reduced (NADH). (Dorland, 27th ed)|Nadide is a dinucleotide of adenine and nicotinamide. It has coenzyme activity in redox reactions and also acts as a donor of ADP-ribose moieties.CertificatesBasic Info-
Product Name:
NAD
Other Name:Adenosine 5′-(trihydrogen diphosphate),P′→5′-ester with 3-(aminocarbonyl)-1-β-D-ribofuranosylpyridinium,inner salt;Pyridinium,3-carbamoyl-1-β-D-ribofuranosyl-,hydroxide,5′→5′-ester with adenosine 5′-(trihydrogen pyrophosphate),inner salt;Adenosine 5′-(trihydrogen diphosphate),P′→5′-ester with 3-(aminocarbonyl)-1-β-D-ribofuranosylpyridinium hydroxide,inner salt;Codehydrase I;Codehydrogenase I;Coenzyme I;Diphosphopyridine nucleotide;DPN;Cozymase I;NAD;Nadide;Nicotinamide-adenine dinucleotide;Oxidized diphosphopyridine nucleotide;Adenine-nicotinamide dinucleotide;NAD+;Enzopride;β-NAD;β-Diphosphopyridine nucleotide;β-Nicotinamide adenine dinucleotide;β-NAD+;NSC 20272;CO-I;β-Nicotinamide adenine dinucleotide hydrate;30429-30-2;159929-29-0;1083039-67-1;1354693-98-3
CAS No.:53-84-9
Molecular Formula:C21H27N7O14P2
InChIKeys:InChIKey=BAWFJGJZGIEFAR-NNYOXOHSSA-N
Molecular Weight:663.43
Exact Mass:663.109131
EC Number:200-184-4
NSC Number:757121
DSSTox ID:DTXSID2045236
NCI Thesaurus Code:C87339
HScode:29349990
Categories:
Characteristics-
PSA:
321
XLogP3:-1.29620
Appearance:White Powder
Melting Point:140-142 °C (decomp)
Water Solubility:soluble in water at 50mg/ml
Storage Conditions:2-8°C
Specific rotation:D20 -31.5° (c = 1.2 in water)
Collision Cross Section:226.7 Ų [M+H]+ [CCS Type: DT, Method: single field calibrated with Agilent tune mix (Agilent)]|227.5 Ų [M+H]+ [CCS Type: DT, Method: single field calibrated with ESI Low Concentration Tuning Mix (Agilent)]|222.7 Ų [M+Na]+ [CCS Type: DT, Method: single field calibrated with ESI Low Concentration Tuning Mix (Agilent)]|223.8 Ų [M-H]- [CCS Type: DT, Method: single field calibrated with ESI Low Concentration Tuning Mix (Agilent)]|230.8 Ų [M+Na-2H]- [CCS Type: DT, Method: single field calibrated with ESI Low Concentration Tuning Mix (Agilent)]|227 Ų [M+H]+ [CCS Type: TW, Method: calibrated with polyalanine and drug standards]
Research-
Class:
Dual agonist — GIPR, GLP-1R
Status:FDA-approved (Mounjaro / Zepbound)
Mechanism:Dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. A 39-amino-acid modified peptide with a C20 fatty diacid moiety that enables albumin binding for extended half-life (~5 days). Selectively activates both GIPR and GLP-1R signaling pathways.
EC50 (Human GLP1R):0.934 nM
EC50 (Human GIPR):0.0224 nM
Source:Frias JP, et al. N Engl J Med. 2021;385(6):503-515.DOI
Clinical Development:NCT03954834; NCT03987919; NCT03882970; NCT03730662; NCT04039503
FDA:Mounjaro, Zepbound (approved 2022-05-13)
References-
ChEMBL:DrugBank:KEGG DRUG:PubChem:Disclaimer:
Tirzepatide is approved as a prescription medicine (Mounjaro, Zepbound) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.
Hazard IdentificationClassification of the substance or mixture
Not classified.
GHS label elements, including precautionary statements
Pictogram(s) No symbol. Signal word No signal word
Hazard statement(s) none
Precautionary statement(s) Prevention none
Response none
Storage none
Disposal none
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Retatrutide
-
Location:
shenzhenshilonggangqulongchengjiedaohuanggekengshequjiazhaoyeshidaidasha902
-
Average lead Time:
15 days
-
Year of Establishment:
2024
-
-
Inquiry History126 Inquiries
Country Product Purchase Quantity Date Posted
United States
NAD
1 KG Oct 26, 2026
India
NAD
100 G Oct 21, 2026
India
NAD+
20 G Sep 30, 2026
United States
NAD
30 MT Sep 29, 2026
United Arab Emirates
NAD
10 MT Sep 19, 2026
Australia
NAD
50 PCS Sep 16, 2026
United States
NAD
30 MG Sep 1, 2026
Philippines
NAD+
15 KG Sep 1, 2026
Philippines
NAD+
15 KG Aug 31, 2026
United Kingdom
NAD+ 500mg for IV therapy
2 MG Aug 11, 2026
United States
NAD+
1 G Aug 7, 2026
United States
NAD+ 500mg / 1000mg
100 MG Aug 7, 2026
United States
NAD+
1000 MG Aug 4, 2026
South Africa
Nad+
10 MT Jul 27, 2026
United States
β-Nicotinamide adenine dinucleotide
10 G Jul 16, 2026
Poland
Fenbendazole
1 KG Jul 14, 2026
United States
NAD
10 MT Jul 9, 2026
United States
NAD+ 500
10000 MG Jul 2, 2026
United States
Beta-Nicotinamide adenine dinucleotide Nad+
1 MG Jun 18, 2026
Australia
Nad
10 MG Jun 16, 2026 Post an enquiry for this product
More from this Seller
-
-
-
Lab Grade IGF-DES CAS No 112603-35-7 Consistent Pure Peptides Powder For Research
Pharmaceutical Grade / 99%
$10/G FOB
-
-
-
-
Lab Grade Cerebrolysin CAS No 12656-61-0 Consistent Pure Peptides Powder For Scientific Research Use
Pharmaceutical Grade / 99%
$10/G FOB
-
-
-
-
Consistent Pure MOTS-c Mitochondrial Derived Peptide CAS No 1627580-64-6 High Purity Peptides Powder For Scientific Research
Pharmaceutical Grade / 99%
$10/G FOB
-
-
-
-
CAS 232544-43-3 Retatrutide Synthetic bioactive peptides freeze dried powder for advanced in vitro biochemical pathway research assays
Pharmaceutical Grade / 99%
$10/G FOB
-
-
-
-
Lab Grade Pinealon Glu Asp Arg CAS No 175175-23-2 Consistent Pure Peptides Powder For Research Use
Pharmaceutical Grade / 99%
$10/G FOB
-
-
-
-
Research Grade 5-Amino-1MQ NNMT Inhibitor CAS No 42464-96-0 High Purity Peptides Powder For Lab Use
Pharmaceutical Grade / 99%
$10/G FOB
-
Hot Related Products
-
NMN, Nicotinamide Mononucleotide, CAS.1094-61-7 -
nmn anti-aging nicotinamide mononucleotide high purity 99.9% white powder Bontac NMN -
NMN;Beta-Nicotinamide Mononucleotide 98% White to off-white powder -
More than 15 years GMP Factory Suppy 99.5% Nicotinamide ribonucleotide Medical Grade CAS1094-61-7 -
β-Nicotinamide Mononucleotide/NMN 99% White powder -
β-Nicotinamide mononucleotide -
Cost-effective sourcing of 99% pure nicotinamide mononucleotide CAS 1094-61-7 raw material -
NMN(β-Nicotinamide mononucleotide) -
99.9% Nicotinamide Mononucleotide (NMN) Supplier for Anti Aging steroid 100% Delivery Guarantee raw powder 99% purity -
1094-61-7 nicotinamide mononucleotide
